Table of Contents
CHAPTER ONE: Executive Summary
- Scope and Methodology
- Market Trends
- World Demand for Diagnostics
- Keys to Success
CHAPTER TWO: Introduction
- Background
- Marketing in a recession - what the experts say about the 4Ps
- Obama' s new deal - boom and bust
- Musings on what form a reformed U.S. system might take
- Status quo and future - impressing investors in a bear market
CHAPTER THREE: Market Trends/Demand Analysis
- Hospital financing
- The role of new deal for the insured, uninsured and underinsured
- Payer response to economic stress
- Demand for esoteric tests
- World market for IVD tests and services
- 2009 Market Estimates (N. America, EU West Europe, Japan, China, Latin
America, India, EU East Europe, ROW)
- 2014 Market Forecasts (N. America, EU West Europe, Japan, China, Latin
America, India, EU East Europe, ROW)
- Economic Conditions in United States of America
- Economic Conditions in Europe
- Economic Conditions in Japan
- Economic Conditions in China
CHAPTER FOUR: Market Overview/Supply Analysis
- Market Analysis, revenue estimates 2007 - 2015
- IVD Sectors Revenues
- Clinical Chemistry,
- Immunoassays - non isotopic Infectious Diseases
- Other Immunos
- Blood Bank Screening
- Hematology
- Microbiology (ID/AST)
- Molecular Microbiology
- Radioimmunoassays
- Coagulation
- Histology/Cytology
- Nucleic Acid Assays
- Blood Grouping/Typing
- Blood Bank Molecular
- Flow Cytometry
- POC -OTC diabetes
- POC -OTC other
- POC -Professional/Hospital
- IVD Events
- New Tests and Technologies
- Abbott Diagnostics
- Adnavance Technologies
- Arbor Vita Corporation
- Arcxis Biotechnologies and Roche
- Assay Designs
- Aureon Laboratories
- Bayer Healthcare
- BD Diagnostics
- bioMerieux
- BRAHMS
- Caris Diagnostics
- CISBIO Bioassays
- Decision Biomarkers
- DexCom
- Diagnostic HYBRIDS
- Fujirebio Diagnostics
- GeneNews
- InVivoScribe Technologies
- Network Biosystems
- Acquisitions, Mergers
- Abbott Diagnostics-Ibis
- Beckman Coulter-Nephromics
- Exiqon A/S-Oncotech
- GE Healthcare-Whatman
- Others
- Collaborations
- Market Expansion Activities
- Lab Services
- Lab Information
- Google
- IBM
- Intel Corporation
- General Data Company Technology
CHAPTER FIVE: Company Profiles
- Abbott Diagnostics
- Beckman Coulter Inc.
- Becton, Dickinson and Company (BD)
- bioMerieux Inc.
- Celera Corporation
- Cellestis Ltd
- Cepheid
- Clarient Inc. (formerly ChromaVision)
- deCode Genetics Inc.
- Genomic Health
- Gen-Probe Inc.
- Immucor, Inc.
- Inverness Medical Innovations
- Luminex Corporation
- Monogram Biosciences, Inc.
- Nanogen
- Ortho Clinical Diagnostics (OCD)
- Qiagen N.V.
- Quidel Corporation
- Roche Diagnostics
- Seegene, Inc.
- Sequenom, Inc.
- Siemens Medical Solutions Diagnostics
- Sysmex Corporation
- Vermillion/Ciphergen Biosystems Inc.
CHAPTER SIX: Conclusion
- Pricing Strategy
- Marketing Strategy
- Supply and Demand
TABLE OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY
- Figure 1-1: Growth Rates Compared: World Regions
CHAPTER TWO: INTRODUCTION
- Table 2-1: Selected IVD Venture Investments
CHAPTER THREE: MARKET TRENDS/DEMAND ANALYSIS
- Table 3-1: Number of People Worldwide Who Get Chronic Diseases Every Year
- Table 3-2: Percent Change in Industrial Productivity, by Country or
Region, December 2007 to December 2008
- Table 3-3: Worldwide In Vitro Diagnostic Reagent Sales by country,
2009-2014
- Table 3-4: Europe Unemployment Rates and % change in GDP
CHAPTER FOUR: Market Overview/Supply Analysis
- Table 4-1 Worldwide In Vitro Diagnostic Reagent Sales by Product Segment,
2009-2014 (Clinical Chemistry, Immunoassays, Blood Bank Screening, Hematology,
Microbiology, Radioimmunoassays, Coagulation, Histology/Cytology, Nucleic Acid
Assays, Blood Grouping/Typing, Blood Bank Molecular, Flow Cytometry, POC OTC
diabetes, POC, OTC Other, POC, Professional/Hospital)
CHAPTER SIX: Conclusion
- Table 6-1: Pricing Structures That Create Value for the Customer
|
Related Report
|
View Cart
